A 26-year-old marketing executive in Mumbai loses 14 kilos in three months. Her Instagram fills with compliments. Friends ask for her “secret.” She smiles and says it is just discipline and calorie control. What she does not mention is the weekly injection sitting inside her refrigerator. Across India, GLP-1 drugs are becoming the new obsession. Medicines like semaglutide and tirzepatide, originally meant for diabetes treatment, are now being marketed as life-changing weight loss solutions. Celebrities praise them. Influencers quietly promote them. Urban clinics are cashing in on the trend. For many Indians struggling with obesity, PCOS, or diabetes, these drugs can genuinely help. Doctors worldwide have called them revolutionary. But India’s problem is not the medicine itself. The problem is the speed, secrecy, and social pressure surrounding it. A country already battling body image issues is now entering an era where thinness can be injected. And the consequences are beginning to show.
The Relationship Crisis Nobody Talks About
